You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Generics
Glaxo, Lilly, Pfizer join race for MN Pharmaceuticals
1 February 2012 - Pharmaceutical giants GlaxoSmithKline Plc (LON:GSK), Eli Lilly & Co (NYSE:LLY) and Pfizer Inc (NYSE:PFE) are said to be in the race for a stake in Turkish generic drug maker Mustafa Nevzat Ilac Sanayii AS, or MN Pharmaceuticals, Bloomberg said on Tuesday quoting informed people...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up

 

 

 

Login
Username:

Password:


Related Headlines

SOHM boosts dermatology product offering in India

FDA okays Lannett's Hydrochlorothiazide Capsules, 12.5 mg

Stada buys product portfolio for central Europe from Gruenenthal

Watson signs settlement agreement with Mallinckrodt

DoJ approves Ranbaxy settlement on manufacturing practices

Stada to distribute up to 35% of 2011 net profit as dividend - CFO

Watson pays USD 394m for Ascent Pharmahealth

Depomed receives notice against Gralise patents by Actavis

The Medicines Company reaches settlement with APP on Angiomax

Sandoz announces launch of two Phase III biosimilars trials

Amerigen, Fosun Omni ink deal for generic oral controlled release products

Prasco to sell generic version of Shire's Carbatrol in US

Amerigen, VIWA to launch generics joint venture

Designed by Create Marketing
Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2013